Levamisole is a low-molecular-weight synthetic compound, (-)-2,3,5,6-tetrahydro-6-phenylimidazo [2, [1] [2] [3] [4] [5] [6] thiazole, used widely in agriculture and veterinary medicine as an anthelminthic agent. It is also capable of stimulating immune responses in a variety of animal species, including man (1, 3, 6, 8) , and has been used successfully in immune therapy of malignant tumors (10, 14) . Its mode of action on the immune system is unknown. Evidence shows that levamisole stimulates phagocytic activity (2) , macrophage F, receptor activity (11) , and in vitro chemotactic activity (7) .
Several lines of evidence show that thymusderived lymphocyte activity is influenced, if not controlled, by macrophage activity. In addition, some lymphocyte functions are dependent upon antigen processing and presentation by macrophages. The precise nature of such macrophage-lymphocyte interaction is currently in question, but the requirement is no longer in doubt (13) . Scollay and Lafferty (12) have shown that sheep lymphocytes in the efferent flow from lymph nodes are more reactive in graft-versus-host reactions than those from the afferent limb of the lymphatic circulation. They have postulated that macrophages within the lymph nodes "groom" the lymphocytes as they pass through the lymph node matrix. The studies by Lipsky and Rosenthal (4, 5) of in vitro macrophage-lymphocyte interactions to form macrophage-lymphocyte rosettes are germane.
Such rosette formation is antigen independent but is enhanced by antigen. Macrophage-lymphocyte rosette formation is not due to F, receptor activity, nor is it a form of phagocytosis.
Thus, a separate class of membrane receptors is responsible for macrophage-lymphocyte interactions.
The specific physical association between lymphocytes and macrophages may be a mechanism by which macrophages influence lymphocyte activity (5) . We have investigated the effects of levamisole on the ability of sheep alveolar macrophages to participate in macrophage-lymphocyte rosette formation. Alveolar macrophages were obtained by bronchopulmonary lavage of anesthetized adult sheep with 150 ml of sterile isotonic saline. The alveolar macrophages were recovered from the saline by centrifugation, suspended in sterile Hanks balanced salts solution (Grand Island Biological Co., Grand Island, N.Y.) containing 1.25% sodium citrate, and again recovered from suspension by centrifugation. The cells were then washed once with sterile Hanks balanced salts solution without citrate and resuspended in Eagle minimum essential medium (Grand Island Biological Co.) containing 10% heat-inactivated fetal bovine serum. Antibiotics added to the Eagle minimum essential medium were: polymixin B sulfate, 100 U/ml; lincomycin HCl monohydrate, 250 ,ug/ml (both from Grand Island Biological Co.); penicillin G, 100 ug/ml (Nutritional Biochemicals Group, Cleveland, Ohio); and streptomycin sulfate, 100 gg/ml (Sigma Chemical Co., St. Louis, Mo.).
Peripheral venous sheep blood was collected in heparinized Vacutainers (Becton-Dickinson, Rutherford, N.J.), and the lymphocytes were isolated by gradient centrifugation with Lymphocyte Separation Medium (Litton Bionetics, Kensington, Md.). The isolated lymphocytes were suspended in Eagle minimum essential medium, supplemented with fetal bovine serum and antibiotics as above, and kept at 4°C until ready for use, never more than 18 h.
The phenomenon of in vitro macrophagelymphocyte rosette formation was described originally in papers by Lipsky and Rosenthal (4, 5), which should be consulted for the experimental details required for its demonstration. A 1-ml suspension containing 106 macrophages was applied to each well of Lab-Tek tissue culture chamber/slides (Miles Laboratories, Naperville, Ill.). The 
